Glenn J. Myatt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Glenn J. Myatt has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Arianna Bassan
Innovatune srl, Italy
4 shared publications - Candice Johnson
InStem
4 shared publications David T. Szabo
PPG Industries, Monroeville, PA 15146, USA
4 shared publications- Kevin P. Cross
InStem
4 shared publications Moiz Mumtaz
Office of the Associate Director for Science, Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
4 shared publicationsAlexander Amberg
Sanofi, R&D Preclinical Safety Frankfurt, Industriepark Hoechst, D-65926 Frankfurt am Main, Germany
3 shared publications
Latest Publications
- 19 December 2023
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 78 (3) , 214-236
In Silico Assessment of Biomolecule Reactivity with Leachables
Leachables in pharmaceutical products may react with biomolecule Active Pharmaceutical Ingredients (APIs) e.g., mAb, peptide, RNA, potentially compromising product safety, efficacy or impacting quality attributes. This investigation explored a series of in silico models to screen extractables and leachables to assess their possible reactivity with biomolecules. These in silico models were applied to collections of known leachables to identify functional and structural chemical classes likely to be flagged by these in silico approaches. Flagged leachable functional classes included antimicrobials, colorants, and film forming agents, while specific chemical classes, included epoxides, acrylates and quinones. In addition, a dataset of 22 leachables with experimental data indicating their interaction with insulin glargine was used to evaluate whether one or more in silico methods are fit-for-purpose as a preliminary screen for assessing this biomolecule reactivity. Analysis of the data concluded that the sensitivity of an in silico screen using multiple methodologies was 80-90% and specificity 58-92%. A workflow supporting the use of in silico methods in this field is proposed based on both the results from this assessment and best practices in the field of computational modelling and quality risk management.
- 19 December 2023
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 78 (3) , 214-236
In Silico Assessment of Biomolecule Reactivity with Leachables
Leachables in pharmaceutical products may react with biomolecule Active Pharmaceutical Ingredients (APIs) e.g., mAb, peptide, RNA, potentially compromising product safety, efficacy or impacting quality attributes. This investigation explored a series of in silico models to screen extractables and leachables to assess their possible reactivity with biomolecules. These in silico models were applied to collections of known leachables to identify functional and structural chemical classes likely to be flagged by these in silico approaches. Flagged leachable functional classes included antimicrobials, colorants, and film forming agents, while specific chemical classes, included epoxides, acrylates and quinones. In addition, a dataset of 22 leachables with experimental data indicating their interaction with insulin glargine was used to evaluate whether one or more in silico methods are fit-for-purpose as a preliminary screen for assessing this biomolecule reactivity. Analysis of the data concluded that the sensitivity of an in silico screen using multiple methodologies was 80-90% and specificity 58-92%. A workflow supporting the use of in silico methods in this field is proposed based on both the results from this assessment and best practices in the field of computational modelling and quality risk management.
- 19 December 2023
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 78 (3) , 237-311
Characterizing Extractables and Leachables Chemical Space to Support In Silico Toxicological Hazard Assessments
This article describes the development of a representative dataset of extractables and leachables (E&L) from the combined Extractables and Leachable Safety Information Exchange (ELSIE) Consortium and the Product Quality Research Institute (PQRI) published datasets, representing a total of 783 chemicals. A chemical structure-based clustering of the combined dataset identified 142 distinct chemical classes with two or more chemicals across the combined dataset. The majority of these classes (105 chemical classes out of 142) contained chemicals from both datasets, whereas 8 classes contained only chemicals from the ELSIE dataset and 29 classes contain only chemicals from the PQRI dataset. This evaluation also identified classes containing chemicals that were flagged as potentially mutagenic as well as potent (strong or extreme) dermal sensitizers by in silico tools. The prevalence of alerting structures in the E&L datasets was approximately 9% (69 examples) for mutagens and 3% (25 examples) for potent sensitizers. This analysis showed that most (80%; 20/25) of E&L predicted to be strong or extreme dermal sensitizers were also flagged as potential mutagens. Only two chemical classes each containing three chemicals (alkyl bromides and isothiocyanates) were uniquely identified in the PQRI dataset and contained chemicals predicted to be potential mutagens and/or potent dermal sensitizers.
- 19 December 2023
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 78 (3) , 237-311
Characterizing Extractables and Leachables Chemical Space to Support In Silico Toxicological Hazard Assessments
This article describes the development of a representative dataset of extractables and leachables (E&L) from the combined Extractables and Leachable Safety Information Exchange (ELSIE) Consortium and the Product Quality Research Institute (PQRI) published datasets, representing a total of 783 chemicals. A chemical structure-based clustering of the combined dataset identified 142 distinct chemical classes with two or more chemicals across the combined dataset. The majority of these classes (105 chemical classes out of 142) contained chemicals from both datasets, whereas 8 classes contained only chemicals from the ELSIE dataset and 29 classes contain only chemicals from the PQRI dataset. This evaluation also identified classes containing chemicals that were flagged as potentially mutagenic as well as potent (strong or extreme) dermal sensitizers by in silico tools. The prevalence of alerting structures in the E&L datasets was approximately 9% (69 examples) for mutagens and 3% (25 examples) for potent sensitizers. This analysis showed that most (80%; 20/25) of E&L predicted to be strong or extreme dermal sensitizers were also flagged as potential mutagens. Only two chemical classes each containing three chemicals (alkyl bromides and isothiocyanates) were uniquely identified in the PQRI dataset and contained chemicals predicted to be potential mutagens and/or potent dermal sensitizers.
- 4 September 2023
- Published by Springer Nature
- p. 1-36
In Silico Toxicology
- 8 February 2023
- Published by Springer Nature
- p. 407-432
The Use of Machine Learning to Support Drug Safety Prediction
- 8 February 2023
- Published by Springer Nature
- p. 407-432
The Use of Machine Learning to Support Drug Safety Prediction
- 14 July 2022
- Published by Elsevier in Computational Toxicology
- Vol. 24
Principles and procedures for assessment of acute toxicity incorporating in silico methods
- 14 July 2022
- Published by Elsevier in Computational Toxicology
- Vol. 24
Principles and procedures for assessment of acute toxicity incorporating in silico methods
- Open Access
- 23 April 2022
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 131, 105165
Corrigendum to a cross-industry collaboration to assess if acute toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling. Regulatory toxicology and pharmacology (2021) 104843
- 23 April 2022
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 131, 105165
Open AccessCorrigendum to a cross-industry collaboration to assess if acute toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling. Regulatory toxicology and pharmacology (2021) 104843
- 1 January 2022
- Published by Springer Nature
- Vol. 2425, 419-434
Implementation of In Silico Toxicology Protocols in Leadscope
In silico toxicology protocols help ensure the results from computational toxicology models are performed and documented in a standardized, consistent, transparent, and accepted manner. In silico toxicology protocols for skin sensitization and genetic toxicology have been previously published and have been implemented within the Leadscope software. The following chapter outlines how such protocols have been deployed in the Leadscope platform including integration with toxicology databases and a battery of computational toxicology models.
- 1 January 2022
- Published by Springer Nature
- Vol. 2425, 419-434
Implementation of In Silico Toxicology Protocols in Leadscope
In silico toxicology protocols help ensure the results from computational toxicology models are performed and documented in a standardized, consistent, transparent, and accepted manner. In silico toxicology protocols for skin sensitization and genetic toxicology have been previously published and have been implemented within the Leadscope software. The following chapter outlines how such protocols have been deployed in the Leadscope platform including integration with toxicology databases and a battery of computational toxicology models.